Scilex started at buy with $4 stock price target at B. Riley Oct. 16, 2023 at 8:25 a.m. ETby Tomi Kilgore Scilex amends license agreement with Romeg Therapeutics Jan. 16, 2025 at 3:45 p.m. ETon TipRanks.com Scilex announces Pain Medicine News published data on ZTildo vs Lidocai...
SK Hynix Inc GDR - 144A(HXSCL) -N/A(N/A%) Bid:89.10x100Ask:155.00x100 January 7, 2025Volume: 0 USDOTC Pink LimitedDelayed Price Earnings Consensus data is not available for symbol. Created with Highcharts 5.0.7Quarter End$ EPS# Estimates$ EPS Actual$ EPS Estimate# Estimates ...
Provide feedback We read every piece of feedback, and take your input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up {...
Stepan Company holds a debt-to-equity ratio of 0.499. At this time, Stepan's Debt To Equity is quite stable compared to the past year. Interest Debt Per Share is expected to rise to 30.89 this year, although the value of Long Term Debt will most likely f
or similar business combination with one or more businesses. The Company is actively searching and identifying suitable business combination targets but has not selected any business combination target. The company’s efforts to identify a prospective target business are not be limited to a particular ...
The principal methods of competition are product performance, price, technical assistance and ability to meet the specific needs of individual customers. These factors allow the Company to compete on bases other than price alone, reducing the severity of competition as experienced in the sales of ...